These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 29187396)

  • 1. Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.
    Haddad Kashani H; Schmelcher M; Sabzalipoor H; Seyed Hosseini E; Moniri R
    Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187396
    [No Abstract]   [Full Text] [Related]  

  • 2. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
    Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
    Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Strategy to Identify Endolysins with Lytic Activity against Methicillin-Resistant
    Kim H; Seo J
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo.
    Imanishi I; Uchiyama J; Tsukui T; Hisatsune J; Ide K; Matsuzaki S; Sugai M; Nishifuji K
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31443379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus.
    Fernandes S; Proença D; Cantante C; Silva FA; Leandro C; Lourenço S; Milheiriço C; de Lencastre H; Cavaco-Silva P; Pimentel M; São-José C
    Microb Drug Resist; 2012 Jun; 18(3):333-43. PubMed ID: 22432707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering Endolysins against Methicillin-Resistant
    Yoda T; Matsuhashi A; Matsushita A; Shibagaki S; Sasakura Y; Aoki K; Hosokawa M; Tsuda S
    ACS Infect Dis; 2024 Aug; 10(8):2679-2689. PubMed ID: 38906534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage endolysins as new therapeutic options for multidrug resistant
    Belete MA; Tadesse S; Tilahun M; Alemayehu E; Saravanan M
    Front Cell Infect Microbiol; 2024; 14():1397935. PubMed ID: 38953006
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of Advanced Chimeric Endolysin to Control Multidrug-Resistant
    Lee C; Kim J; Son B; Ryu S
    ACS Infect Dis; 2021 Aug; 7(8):2081-2092. PubMed ID: 34047546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
    Basit A; Qadir S; Qureshi S; Rehman SU
    Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of the lytic domain of endolysin from Staphylococcus aureus bacteriophage in milk.
    Yan J; Yang R; Yu S; Zhao W
    J Dairy Sci; 2021 Mar; 104(3):2641-2653. PubMed ID: 33358804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
    Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
    Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.
    Gerstmans H; Rodríguez-Rubio L; Lavigne R; Briers Y
    Biochem Soc Trans; 2016 Feb; 44(1):123-8. PubMed ID: 26862197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
    Liu H; Hu Z; Li M; Yang Y; Lu S; Rao X
    J Biomed Sci; 2023 Apr; 30(1):29. PubMed ID: 37101261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus Bacteriophage 52 Endolysin Exhibits Anti-Biofilm and Broad Antibacterial Activity Against Gram-Positive Bacteria.
    Abdurahman MA; Durukan İ; Dinçer T; Pektaş S; Karataş E; Kiliç AO
    Protein J; 2023 Oct; 42(5):596-606. PubMed ID: 37634214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.
    Schmelcher M; Shen Y; Nelson DC; Eugster MR; Eichenseher F; Hanke DC; Loessner MJ; Dong S; Pritchard DG; Lee JC; Becker SC; Foster-Frey J; Donovan DM
    J Antimicrob Chemother; 2015 May; 70(5):1453-65. PubMed ID: 25630640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endolysin LysSA97 is synergistic with carvacrol in controlling Staphylococcus aureus in foods.
    Chang Y; Yoon H; Kang DH; Chang PS; Ryu S
    Int J Food Microbiol; 2017 Mar; 244():19-26. PubMed ID: 28063330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Advantages and Challenges of Using Endolysins in a Clinical Setting.
    Murray E; Draper LA; Ross RP; Hill C
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Phage-Derived Antimicrobial Agent HY-133 Is Active against Livestock-Associated Methicillin-Resistant Staphylococcus aureus.
    Kaspar U; de Haro Sautto JA; Molinaro S; Peters G; Idelevich EA; Becker K
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
    Briers Y; Lavigne R
    Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic antimicrobial peptides as enhancers of the bacteriolytic action of staphylococcal phage endolysins.
    Gouveia A; Pinto D; Veiga H; Antunes W; Pinho MG; São-José C
    Sci Rep; 2022 Jan; 12(1):1245. PubMed ID: 35075218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.